High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network
about
Rates and predictors of adherence to psychotropic medications in children with autism spectrum disorders.Obesity Prevention for Children with Developmental Disabilities.Aberrant Behaviors and Co-occurring Conditions as Predictors of Psychotropic Polypharmacy among Children with Autism Spectrum Disorders.Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.Age-related variation in health service use and associated expenditures among children with autismPsychotropic medication use and polypharmacy in children with autism spectrum disorders.Prescription Drug Use and Polypharmacy Among Medicaid-Enrolled Adults with Autism: A Retrospective Cross-Sectional AnalysisPharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.School-aged functioning of children diagnosed with autism spectrum disorder before age three: parent-reported diagnostic, adaptive, medication, and school placement outcomes.Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study.Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.Polypharmacy in pediatric patients and opportunities for pharmacists' involvement.Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study.Predictors of emergency service use in adolescents and adults with autism spectrum disorder living with family.
P2860
Q34424843-F5F2F148-B294-4615-A3F5-CDA969E05F69Q34711543-A130F137-13D9-4888-A044-990EFAFA9A2EQ35641660-B7EBA02E-818A-410F-ACA4-2DC375264E21Q36113601-2FFEB2FC-E65A-4833-8B8F-4DC8F8336AF7Q36631879-802BA9B5-2597-4C50-922D-6003C88BB421Q37268793-432F7057-11A4-49CA-BCC6-0058B1028FD9Q37452761-44DED679-3465-42B5-8EFD-303E56C28E62Q37598430-5C698ADA-5CBC-4D65-8297-A2090859E64EQ38171993-E5443B9D-44B6-4791-97C6-8B216EB0877EQ38953538-6E41E383-B107-44E0-B2F1-171D39721D68Q41648983-B6958F5D-F05A-4DBC-91A9-3E3665A7AF13Q44569444-AE682424-3AC7-481B-B557-C1C7BC5D34C5Q45298736-04488E8F-CF3F-47E5-AE35-7B509FD951F9Q49206945-830A2F57-9739-4278-8060-B2FDC4EBC25DQ50204761-23164ACA-52B4-46B7-9181-AC48C350432CQ50302892-03168EBE-5F55-411A-BCEE-8F38E1BFE609
P2860
High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
High prescription drug use and ...... ion-based surveillance network
@ast
High prescription drug use and ...... ion-based surveillance network
@en
type
label
High prescription drug use and ...... ion-based surveillance network
@ast
High prescription drug use and ...... ion-based surveillance network
@en
prefLabel
High prescription drug use and ...... ion-based surveillance network
@ast
High prescription drug use and ...... ion-based surveillance network
@en
P2093
P2860
P1476
High prescription drug use and ...... ion-based surveillance network
@en
P2093
Elizabeth Garrett-Mayer
Jane M Charles
Joyce S Nicholas
Laura A Carpenter
Lydia B King
Sarah L Logan
P2860
P356
10.1016/J.ANNEPIDEM.2011.10.007
P577
2012-01-01T00:00:00Z